Pandion Therapeutics is a biotechnology company developing bispecific antibody therapeutics to achieve localized immunomodulation at the site of disease for durable, tissue-specific treatment, while avoiding the systemic immunosuppression of conventional medicines.

Company Name

Pandion Therapeutics (PAND)

Company Website

https://pandiontx.com/

Location

Cambridge, Mass.

Investment Stage

IPO July 2020